Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 2/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | CSF1R | P07333 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | NQO1 | P15559 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22073734 | 0.90 | LPL (0.38) | LPLLIPGMAOAMEN1NPC1 | |
| SCHEMBL24223701 | 0.86 | AHR (0.46) | LPLLIPGCSF1RELANE | |
| SCHEMBL24223702 | 0.86 | AHR (0.46) | LPLLIPGMEN1NPC1KMT2A | |
| SCHEMBL24542161 | 0.82 | LPL (0.40) | LPLLIPGMEN1KMT2AALDH1A1 | |
| SCHEMBL24542566 | 0.80 | LPL (0.39) | LPLLIPGMAOAMEN1NPC1 | |
| SCHEMBL19917048 | 0.79 | LPL (0.41) | LPLLIPGMAOANPC1 | |
| SCHEMBL24542133 | 0.79 | LPL (0.38) | LPLLIPGALDH1A1 | |
| SCHEMBL732170 | 0.78 | LPL (0.47) | LPLLIPGMAOAMEN1KMT2A | |
| SCHEMBL29298701 | 0.78 | LPL (0.45) | LPLLIPGCSF1R | |
| SCHEMBL19986403 | 0.78 | LPL (0.39) | LPLLIPGCSF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11380846-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-07-05 | — | — | US | disclosed |
| US-20180083197-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
| US-20180083197-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11380846-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | PIEZO1, OCIAD1, LEF1 | LPL 2598/4885LIPG 1295/4885MAOA 478/4885 |
| US-20180083197-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, LEF1 | LPL 2598/4885LIPG 1295/4885MAOA 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.